Genetic Deficiencies of Complement

References

• Colten H R, Rosen F S. Complement deficiencies. Annu Rev Immunol 1992; 10: 809–34
   PubMed Web of Science ®Google Scholar
• Morgan B R, Walport M J. Complement deficiency and disease. Immunol Today 1991; 12: 301–6
   PubMedGoogle Scholar
• Wüzner R, Orren A, Lachmann P J. Inherited deficiencies of the terminal components of human complement. Immunodefic Rev 1992; 3: 123–42
   PubMedGoogle Scholar
• Müller-Eberhard H J. Complement. Annu Rev Biochem 1975; 44: 697–724
   PubMed Web of Science ®Google Scholar
• Müller-Eberhard H J. Molecular organization and function of the complement system. Annu Rev Biochem 1988; 57: 321–47
   PubMed Web of Science ®Google Scholar
• Welsh R M, Cooper N R, Jensen F C, Oldstone M BA. Human serum lyses RNA tumor viruses. Nature 1975; 257: 612–4
   PubMed Web of Science ®Google Scholar
• Cooper N R, Jensen F C, Welsh R M, Oldstone M BA. Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway. J Exp Med 1976; 144: 970–84
   PubMed Web of Science ®Google Scholar
• Bartholomew R M, Esser A F. Mechanism of antibody-independent activation of the first component of complement (C1) on retrovirus membranes. Biochemistry 1980; 19: 2847–53
   PubMed Web of Science ®Google Scholar
• Kaplan M H, Volanakis J E. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with choline phosphatides, lecithin and sphingomyelin. J Immunol 1974; 112: 2135–47
   PubMed Web of Science ®Google Scholar
• Richards R L, Gewurz H, Osmand A P, Alving C R. Interactions of C-reactive protein and complement with liposomes. Proc Natl Acad Sci USA 1977; 74: 5672–6
   PubMed Web of Science ®Google Scholar
• Storrs S B, Kolb W P, Plnckard R N, Olson M S. Characterization of the binding of purified human C1q to heart mitochondrial membranes. J Biol Chem 1981; 256: 10924–9
   Google Scholar
• Pangburn M K, Müller-Eberhard H J. The alternative pathway of complement. Springer Semin Immunopathol 1984; 7: 163–92
   PubMed Web of Science ®Google Scholar
• Cooper N R, Nemerow G R. Complement, viruses, and virus-infected cells. Springer Semin Immunopathol 1983; 6: 327–47
   PubMed Web of Science ®Google Scholar
• Vogt W, Dames W, Schmidt G, Dieminger L. Complement activation by the properdin system: formation of a stoichiometric C3 cleaving complex of properdin factor B with C3b. Immunochemistry 1977; 14: 201–5
   PubMedGoogle Scholar
• Fearon D T, Austen K F, Ruddy S. Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement. J Exp Med 1973; 138: 1305–13
   PubMed Web of Science ®Google Scholar
• Hugli T E. Biochemistry and biology of anaphylatoxins. Complement 1986; 3: 111–27
   PubMedGoogle Scholar
• Frank M M, Fries L F. The role of complement in inflammation and phagocytosis. Immunol Today 1991; 12: 322–6
   PubMedGoogle Scholar
• Schifferli J A, Woo P, Peters D K. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways. Clin Exp Immunol 1982; 47: 555–62
   PubMed Web of Science ®Google Scholar
• Müller-Eberhard H J. The membrane attack complex of complement. Annu Rev Immunol 1986; 4: 503–28
   Google Scholar
• Zipfel P F, Skerka C. Complement factor H and related proteins: an expanding family of complement-regulatory proteins?. Immunol Today 1994; 15: 121–6
   PubMedGoogle Scholar
• Hourcade D, Holers V M, Atkinson J P. The regulators of complement activation (RCA) gene cluster. Adv Immunol 1989; 45: 381–416
   PubMed Web of Science ®Google Scholar
• Podack E R, Müller-Eberhard H J. Isolation of human S-protein, an inhibitor of the membrane attack complex of complement. J Biol Chem 1979; 254: 9808–14
   PubMed Web of Science ®Google Scholar
• Salvesen G S, Catanese J J, Kress L F, Travis J. Primary structure of the reactive site of human C1 inhibitor. J Biol Chem 1985; 260: 2432–6
   PubMed Web of Science ®Google Scholar
• Atkinson J P, Farries T J. Separation of self from non-self in the complement system. Immunol Today 1987; 8: 212–5
   PubMedGoogle Scholar
• Liszewski M K, Tedja I, Atkinson J P. Membrane cofactor protein (CD46) of complement. J Biol Chem 1994; 269: 10776–9
   PubMed Web of Science ®Google Scholar
• Kinoshita T, Medof M E, Silber R, Nussenzweig V. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med 1985; 162: 75–92
   PubMed Web of Science ®Google Scholar
• Lublin D M, Atkinson J P. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu Rev Immunol 1989; 7: 35–58
   PubMed Web of Science ®Google Scholar
• Rollins S A, Sims P J. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J Immunol 1990; 144: 3478–83
   PubMed Web of Science ®Google Scholar
• Fearon D T, Wong W W. Complement ligand-receptor interactions that mediate biological responses. Annu Rev Immunol 1983; 1: 243
   PubMed Web of Science ®Google Scholar
• Winkelstein J A, Sullivan K E, Colten H R. Genetically determined disorders of the complement system. The Metabolic Basis of Inherited Disease, 7th edn., C R Scriver. McGraw-Hill, New York 1995; 3911–41
   Google Scholar
• Colten H R. Deficiencies of the first component of complement (C1): an update. Behring Inst Mitt 1993; 93: 287–91
   Google Scholar
• Figueroa J E, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 1991; 4: 359–95
   PubMed Web of Science ®Google Scholar
• Hauptmann G, Tappeiner G, Schifferll J A. Inherited deficiency of the fourth component of human complement. Immunodefic Rev 1988; 1: 3–22
   PubMedGoogle Scholar
• Fielder A HL, Walport M J, Batchelor J R, et al. Family study of the MHC in patients with SLE: importance of null alleles of C4A and C4B in determining disease susceptibility. BMJ 1983; 286: 425–8
   PubMed Web of Science ®Google Scholar
• Wilson W A, Perez M C. Complete C4B deficiency in black Americans with systemic lupus erythematosus. J Rheumatol 1988; 15: 1855–8
   PubMed Web of Science ®Google Scholar
• Dunckley H, Gatenby P A, Hawkins B, Naito S, Serjeantson S W. Deficiency of C4A is a genetic determinant of systemic lupus erythematosus in three ethnic groups. J Immunogenet 1987; 14: 209–18
   PubMedGoogle Scholar
• Einstein L P, Alper C A, Bloch K H, et al. A biosynthetic defect in monocytes from humans with genetic deficiency of the second component of complement (C2). N Engl J Med 1975; 292: 1169–71
   PubMed Web of Science ®Google Scholar
• Gelfand E W, Clarkson J O, Minta J O. Selective deficiency of the second component of complement in a patient with anaphylactoid purpura. Clin Immunol Immunopathol 1975; 4: 269–76
   PubMedGoogle Scholar
• Leddy J P, Griggs R C, Klemperer M R, Frank M M. Hereditary complement C2 deficient with dermatomyositis. Am J Med 1975; 58: 83–91
   PubMed Web of Science ®Google Scholar
• Friend P, Repine J, Kim Y, Clawson C C, Michael A F. Deficiency of the second component of complement (C2) with chronic vasculitis. Ann Int Med 1975; 83: 813–6
   PubMed Web of Science ®Google Scholar
• Kim Y, Friend P S, Dresner I G, Yunis E J, Michael A F. Inherited deficiency of the second component of complement (C2) deficiency with membranoproliferative glomerulonephritis. Am J Med 1977; 62: 765–71
   PubMed Web of Science ®Google Scholar
• Levy S B, Pinnell S R, Meadows L, Snyderman R, Ward F E. Hereditary C2 deficiency associated with cutaneous lupus erythematosus: clinical, laboratory and genetic studies. Arch Dermatol 1979; 115: 57–61
   PubMedGoogle Scholar
• Perlmutter D H, Colten H R. Molecular basis of complement deficiencies. Immunodefic Rev 1989; 1: 105–33
   PubMedGoogle Scholar
• Cooper N R. The classical complement pathway: activation and regulation of the first complement component. Adv Immunol 1985; 37: 151–216
   PubMed Web of Science ®Google Scholar
• Tosi M, Duponchel C, Meo T, Juller C. Complete cDNA sequence of human complement C1s and close physical linkage of the homologous genes C1s and C1r. Biochemistry 1987; 26: 8516–24
   PubMed Web of Science ®Google Scholar
• Nguyen V C, Tosi M, Gross M S, et al. Assignment of the complement serine protease genes C1r and C1s to chromosome 12 region 12p13. Hum Genet 1988; 78: 363–8
   PubMed Web of Science ®Google Scholar
• McAdam R A, Goundis D, Reld K B. .99 A homozygous point mutation results in a stop codon in the C1q B-chain of a C1q deficient individual. Immunogenetics 1988; 27: 259–64
   PubMed Web of Science ®Google Scholar
• Petry F, Le D T, Kirschfink M, Starsia Z, Loos M. Molecular characterization of the C1q genes of patients with various types of C1q deficiency (abstract). III. International Workshop on C1 –- The First Component of Complement, M Loos, MainzGermany 1992
   Google Scholar
• Thompson R A, Haeney M, Reid K BM, Davies J G, White R HR, Cameron A H. A genetic defect of the C1q subcomponent of complement associated with childhood (immune complex) nephritis. N Engl J Med 1980; 303: 22–4
   PubMed Web of Science ®Google Scholar
• Reid K BM, Thompson R A. Characterization of a nonfunctional form of C1q found in patients with a genetically linked deficiency of C1q activity. Mol Immunol 1983; 20: 1117–25
   PubMed Web of Science ®Google Scholar
• Skok J, Solomon E, Reid K B, Thompson R A. Distinct genes for fibroblast and serum C1q. Nature 1981; 292: 549–51
   PubMed Web of Science ®Google Scholar
• Chapuis R M, Hauptmann G, Grosshans E, Isliker H. Structural and functional studies in C1q deficiency. J Immunol 1982; 129: 1509–12
   PubMed Web of Science ®Google Scholar
• Hannema A J, Kluin-Nelemans H C, Hack C E, Malee C, van Helden H PT, Eerenberg-Belmer A JM. A functional deficiency of C1q in three family members (abstract). Mol Immunol 1982; 19: 1373
   Web of Science ®Google Scholar
• Reid K B. Deficiency of the first component of human complement. Immunodefic Rev 1989; 1: 247–60
   PubMedGoogle Scholar
• Suzuki Y, Ogura Y, Otsubo O, Akagi K, Fujita T. Selective deficiency of C1s associated with a systemic lupus eryhtematosus-like syndrome. Report of a case. Arthritis Rheum 1992; 35: 576–9
   PubMedGoogle Scholar
• Hall R E, Colten H R. Cell-free synthesis of the fourth component of guinea pig complement (C4): Identification of a precursor of serum C4 (pro-C4). Proc Natl Acad Sci USA 1977; 74: 1707–10
   PubMed Web of Science ®Google Scholar
• Karp D R. Post-translational modification of the fourth component of complement. Effect of tunicamycin and amino acid analogs on the formation of the internal thiolester disulfide bonds. J Biol Chem 1983; 258: 14490
   PubMed Web of Science ®Google Scholar
• Chan A C, Mitchell K R, Munns T W, Karp D R, Atkinson J P. Identification and partial characterization of the secreted form of the fourth component of human complement: Evidence that it is different from the major plasma form. Proc Natl Acad Sci USA 1983; 80: 268
   PubMed Web of Science ®Google Scholar
• Carroll M C, Campbell R D, Bentley D R, Porter R R. A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature 1984; 307: 237–41
   PubMed Web of Science ®Google Scholar
• Paisdottir A, Fossal R, Arnason A, Edwards J H, Jenssen O. Heterogeneity of human C4 gene size. Immunogenetics 1987; 25: 299–304
   PubMedGoogle Scholar
• Yu C Y. The complete exon-intron structure of a human complement component C4A gene. J Immunol 1991; 146: 1057–66
   PubMed Web of Science ®Google Scholar
• Yu C Y, Belt K T, Glles C M, Campbell R D, Porter R R. Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity. EMBO J 1986; 5: 2873–81
   PubMed Web of Science ®Google Scholar
• Dodds A W, Law S K, Porter R R. The purification and properties of some less common allotypes of the fourth component of human complement. Immunogenetics 1986; 24: 279–85
   PubMed Web of Science ®Google Scholar
• Carroll M C, Fathallah D M, Bergamaschlnl L, Allcot E M, Isenman D E. Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A. Proc Natl Acad Sci USA 1990; 87: 6868–72
   PubMed Web of Science ®Google Scholar
• Schneider P M, Carroll M C, Alper C A, et al. Polymorphism of the human complement C4 and Steroid 21-hydroxylase genes. J Clin Invest 1986; 78: 650–7
   PubMed Web of Science ®Google Scholar
• Braun L, Schneider P M, Giles C M, Bertrams J, Rittner C. Null alleles of human complement C4. J Exp Med 1990; 171: 129–40
   PubMed Web of Science ®Google Scholar
• Partanen J, Campbell R D. Restriction fragment analysis of non-deleted complement C4 null genes suggests point mutations in C4A null alleles, but gene conversion in C4B null alleles. Immunogenetics 1989; 30: 520–3
   PubMed Web of Science ®Google Scholar
• Barba G, Rittner C, Schneider P M. Genetic basis of human complement C4A deficiency. J Clin Invest 1993; 91: 1681–6
   PubMed Web of Science ®Google Scholar
• Uring-Lambert B, Mascart-Lemone F, Tongio M-M, Goetz J, Hauptmann G. Molecular basis of complete C4 deficiency. Human Immunol 1989; 24: 125–32
   PubMed Web of Science ®Google Scholar
• Nordin Fredrikson G, Truedsson L, Sjöholm A G, Kjeilman M. DNA analysis in a MHC heterozygous patient with complete C4 deficiency–-homozygosity for C4 gene deletion and C4 pseudogene. Exp Clin Immunogenet 1991; 8: 29–37
   PubMedGoogle Scholar
• Liszewski M K, Atkinson J P. The role of complement in autoimmunity. Immunol Ser 1991; 54: 97–140
   PubMedGoogle Scholar
• Sjöholm A G. Inherited complement deficiency states and disease. Complement Inflamm 1991; 8: 341–6
   PubMedGoogle Scholar
• Fan Q, Uring-Lambert B, Weill B, Gautreau C, Menkes C J, Deipech M. Complement component C4 deficiencies and gene alterations in a patient with systemic lupus erythematosus. Eur J Immunogen 1993; 20: 11–21
   PubMedGoogle Scholar
• Howard P F, Hochberg M C, Bias W B, Arnett F C, Jr., McLean R H. Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and Black Americans. Am J Med 1986; 81: 187–93
   PubMed Web of Science ®Google Scholar
• Olsen M L, Goldstein R, Arnett F C, Duvic M, Pollack M, Reveille J D. C4a gene deletion and HLA associations in black Americans with systemic lupus erythematosus. Immunogenetics 1989; 30: 27–33
   PubMed Web of Science ®Google Scholar
• Sturfelt G, Truedsson L, Johansen P, Jonsson H, Nived O, Sjöholm A G. Homozygous C4A deficiency in systemic lupus erythematosus: analysis of patients from a defined population. Clin Genet 1990; 38: 427–33
   PubMed Web of Science ®Google Scholar
• Kumar A, Kumar P, Schur P H. DR3 and nonDR3 associated complement component C4A deficiency in systemic lupus erythematosus. Clin Immunol Immunopathol 1991; 60: 55–64
   PubMedGoogle Scholar
• Schifferli J, Steiger G, Paccaud J-P, Sjöholm A, Hauptmann G. Differences in the biological properties of the two forms of the fourth component of human complement (C4). Clin Exp Immunol 1986; 63: 473–7
   PubMed Web of Science ®Google Scholar
• Isenman D, Young J. The molecular basis for the difference in immune hemolysis activity of the chido and rodgers isotypes of human complement component C4. J Immunol 1984; 132: 3019–27
   PubMed Web of Science ®Google Scholar
• Lokki M-L, Meri S, Partanen J, Koskimies S. High frequencies of B8.DR3 and C4A null alleles and immunological disorders in a family of four generations. J Clin Lab Immunol 1990; 31: 161–5
   PubMedGoogle Scholar
• Hauptmann G. Frequency of complement deficiencies in man, disease associations and chromosome assignment of complement genes and linkage groups. Complement Inflamm 1989; 6: 74–80
   PubMedGoogle Scholar
• Vergani D, Wells L, Larcher V F, et al. Genetically determined low C4: a predisposing factor to autoimmune chronic active hepatitis. Lancet 1985; 2: 294–8
   PubMed Web of Science ®Google Scholar
• Scully L J, Toze C, Sengar D P, Goldstein R. Early-onset autoimmune hepatitis is associated with a C4a gene deletion. Gastroenterology 1993; 104: 1478–84
   PubMed Web of Science ®Google Scholar
• Venneker G T, Westerhof W, de Vries I J, et al. Molecular heterogeneity of the fourth component of complement (C4) and its genes in vitiligo. J Invest Dermatol 1992; 99: 853–8
   PubMed Web of Science ®Google Scholar
• de Messias I JT, Santamaria J, Brenden M, Rels A, Mauff G. Association of C4B deficiency (C4B*Q0) with erythema nodosum in leprosy. Clin Exp Immunol 1993; 92: 284–7
   PubMed Web of Science ®Google Scholar
• Moriuchi J, Ichikawa Y, Takaya M, et al. Association of the complement allele C4AQ0 with primary Sjögren's syndrome in Japanese patients. Arthritis Rheum 1991; 34: 224–7
   PubMedGoogle Scholar
• Cameron P U, Mallal S A, French M A, Dawkins R L. Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations. Hum Immunol 1990; 29: 282–95
   PubMed Web of Science ®Google Scholar
• Laitinen T, Lokki M-L, Tulppala M, Ylikorkala O, Koskimies S. Increased frequency of complement C4 ‘null’ alleles in recurrent spontaneous abortions. Hum Reprod 1991; 6: 1384–7
   PubMed Web of Science ®Google Scholar
• Bishof N A, Welch T R, Beischel L S. C4B deficiency: a risk factor for bacteremia with encapsulated organisms. J Infect Dis 1990; 162: 248–50
   PubMed Web of Science ®Google Scholar
• Ishikawa N, Nonaka M, Wetsel R A, Colten H R. Murine complement C2 and factor B genomic and cDNA cloning reveals different mechanisms for multiple transcripts of C2 and B. J Biol Chem 1990; 265: 19040–6
   PubMed Web of Science ®Google Scholar
• Ishii Y, Zhu Z-B, Macon K J, Volanakis J E. Structure of the human C2 gene. J Immunol 1993; 151: 170–4
   PubMed Web of Science ®Google Scholar
• Woods D E, Edge M D, Colten H R. Isolation of a complementary DNA clone for the human complement protein C2 and its use in the identification of a restriction fragment length polymorphism. J Clin Invest 1984; 74: 634–8
   PubMed Web of Science ®Google Scholar
• Cross S J, Edwards J M, Bentley D R, Campbell R D. DNA polymorphism of the C2 and factor B genes. Detection of a restriction fragment length polymorphism which subdivides haplotypes carrying the C2 and factor BF alleles. Immunogenetics 1985; 21: 39–48
   PubMed Web of Science ®Google Scholar
• Zhu Z B, Volanakis J E. Allelic associations of a multiple RFLPs of the gene encoding complement protein C2. Am J Hum Genet 1990; 46: 956–62
   PubMed Web of Science ®Google Scholar
• Zhu Z B, Hsieh S-L, Bentley D R, Campbell R D, Volanakis J E. A variable number of tandem repeats locus within the human complement C2 gene is associated with a retroposon derived from a human endogenous retrovirus. J Exp Med 1992; 175: 1783–7
   PubMed Web of Science ®Google Scholar
• Simon S, Awdeh Z, Campbell R D, et al. A restriction fragment of the C2 gene is a unique marker for C2 deficiency and the uncommon C2 allele C2*B. J Clin Invest 1991; 88: 2142–5
   PubMed Web of Science ®Google Scholar
• Perimutter D H, Cole F S, Goldberger G, Colten H R. Distinct primary translation products from human liver mRNA give rise to secreted and cell-associated forms of complement protein C2. J Biol Chem 1984; 259: 10380–5
   PubMed Web of Science ®Google Scholar
• Cheng J, Volanakis J E. Alternatively spliced transcripts of the human complement C2 gene. J Immunol 1994; 152: 1774–82
   PubMed Web of Science ®Google Scholar
• Akama H, Johnson C A, Colten H R. Human complement protein C2: alternative splicing generates templates for secreted and intracellular C2 proteins. J Biol Chem 1995; 270: 2674–8
   PubMed Web of Science ®Google Scholar
• Bentiey D R. Primary structure of human complement component C2. Biochem J 1986; 239: 339–45
   PubMed Web of Science ®Google Scholar
• Strang C J, Cholin S, Spragg J, et al. Angioedema induced by a peptide derived from complement component C2. J Exp Med 1988; 168: 1685–98
   PubMed Web of Science ®Google Scholar
• Johnson C A, Densen P, Wetsel R A, Cole F S, Goeken N E, Colten H R. Molecular heterogeneity of C2 deficiency. N Engl J Med 1992; 326: 871–4
   PubMed Web of Science ®Google Scholar
• Ruddy S. Complement deficiencies: The second component. Prog Allergy 1986; 39: 250–66
   PubMedGoogle Scholar
• Awdeh Z L, Raum D D, Glass D, et al. Complement –- human histocompatibility antigen haplotypes in C2 deficiency. J Clin Invest 1981; 67: 581
   PubMed Web of Science ®Google Scholar
• Hauptmann G, Tongio M M, Goetz J, et al. Association of the C2 deficiency gene (C2*Q0) with the C4A*4, C4B*2 genes. J Immunogenet 1982; 9: 127
   PubMedGoogle Scholar
• Johnson C A, Densen P, Hurford R K, Jr., Colten H R, Wetsel R A. Type I human complement C2 deficiency. J Biol Chem 1992; 267: 9347–53
   PubMed Web of Science ®Google Scholar
• Truedsson L, Alper C A, Awdeh Z L, Johansen P, Sjöholm A G, Sturfelt G. Characterization of type I complement C2 deficiency MHC haplotypes. Strong conservation of the complotype /HLA-B-region and absence of disease association due to linked class II genes. J Immunol 1993; 151: 5856–63
   PubMed Web of Science ®Google Scholar
• Kulics J, Kiepiela P, Johnson C A, et al. Type II human C2 deficiency: a single amino acid change inhibits secretion (Abstract). Mol Immunol 1993; 30: 26
   Google Scholar
• Botto M, Fong K Y, So A K, Rudge A, Walport M J. Molecular basis of hereditary C3 deficiency. J Clin Invest 1990; 86: 1158–63
   PubMed Web of Science ®Google Scholar
• Lin C-Y, Huang J-L. Molecular study of a Chinese C3 deficient patient. Mol Immunol 1993; 30: 29
   Google Scholar
• Botto M, Fong K Y, So A K, et al. Homozygous hereditary C3 deficiency due to a partial gene deletion. Proc Natl Acad Sci USA 1992; 89: 4957–61
   PubMed Web of Science ®Google Scholar
• Singer L, Kramer J, Borzy M S, Wetsel R A. Evidence of molecular heterogeneity causing inherited human C3 deficiency. Complement Inflamm 1991; 8: 224–5
   Google Scholar
• Singer L, Colten H R, Wetsel R A. Complement C3 deficiency: human, animal, and experimental models. Pathobiology 1994; 62: 14–28
   PubMed Web of Science ®Google Scholar